Fig 3.

Treatment variation among practice sites. Primary treatment distribution from 1990 to 2006 at each clinical site for patients with localized prostate cancer. Sites had at least 30 patients. Clinical sites are arranged in order of increasing average disease risk as assessed by the mean Cancer of the Prostate Risk Assessment (CAPRA) score for that site (listed on x-axis). WW, watchful waiting; RP, radical prostatectomy; Brachy, brachytherapy; EBRT, external-beam radiation therapy; Cryo, cryoablation; PADT, primary androgen deprivation therapy.